Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nephros Inc (NQ: NEPH )

2.060 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6
Open 2.060
Bid (Size) 2.030 (1)
Ask (Size) 2.410 (1)
Prev. Close 2.060
Today's Range 2.060 - 2.060
52wk Range 1.315 - 4.043
Shares Outstanding 10,544,139
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GEE Group And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
NEPH Stock Earnings: Nephros Beats EPS, Misses Revenue for Q1 2024
NEPH stock results show that Nephros beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-39.94%
-39.94%
1 Month
-10.04%
-10.04%
3 Month
-6.79%
-6.79%
6 Month
-33.12%
-33.12%
1 Year
+15.73%
+15.73%

More News

Read More
Nephros Announces Financial Results for Quarter Ended March 31, 2024
Via NewMediaWire
Nephros Announces Financial Results for Quarter Ended March 31, 2024
Via TheNewswire.com
Nephros Schedules First Quarter 2024 Financial Results Conference Call
Via NewMediaWire
Nephros to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Via NewMediaWire
Nephros: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For Nephros
Via Benzinga
Nephros Inc. (NASDAQ: NEPH) Near the Top of Equities by Percentage Gain on 12/13
Via Investor Brand Network
Nephros to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Via TheNewswire.com
NEPH Stock Earnings: Nephros Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Via NewMediaWire
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
Via NewMediaWire
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
Via TheNewswire.com
Nephros: Q3 Earnings Insights
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
11 Consumer Discretionary Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Insiders Buying Delcath Systems And 3 Other Penny Stocks
Via Benzinga
Topics Stocks
Exposures US Equities
Nephros Announces Results for Quarter Ended September 30, 2023
Via NewMediaWire
Nephros Hires Judy Krandel as Chief Financial Officer
Via NewMediaWire
Nephros Schedules Third Quarter 2023 Financial Results Conference Call
Via NewMediaWire
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.